Inovio Pharma (INO) Misses Q4 EPS by 5c
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.21 +5.22%
Financial Fact:
Grant and miscellaneous revenue: 9.41M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Grant and miscellaneous revenue: 9.41M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q4 EPS of ($0.22), $0.05 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $125 thousand versus the consensus estimate of $339.28 thousand.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- 374Water Inc (SCWO) Misses Q2 EPS by 15c
- DeFi Technologies (DEFT) PT Lowered to $1 at Benchmark Following Q2 Miss
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
